California freshwater fish found to be teeming with parasites. How to keep from getting sick
The parasites are called trematodes. Two species of the flatworms were discovered in California's freshwater fish, according to a study published Tuesday in the Journal of Infectious Diseases. The tiny, flattened and sluglike creatures can cause gastrointestinal problems, weight loss and lethargy when a person eats an infected fish.
In some rare and severe cases, the parasites have caused strokes or heart attacks.
'Americans don't usually think about parasites when they eat freshwater fish because it hasn't historically been an issue here,' said Ryan Hechinger, the study's senior author.
In fact, even when a person has fallen ill from a locally caught infected freshwater fish, their healthcare provider will typically ask if the patient has recently traveled outside of the United States, Hechinger said.
Researchers identified two species of trematode: Haplorchis pumilio and Centrocestus formosanus.
These two parasite species have historically infected people in Southeast Asia who eat raw fish, crustaceans or vegetables that carry the parasite larvae.
A trematode has a very specific life cycle, leeching onto three hosts that include a freshwater snail, a fish and then a bird or human who ate the infected fish.
The parasite was probably carried to the U.S. by the red-rimmed melania, or Malaysian trumpet snail, which is host to a number of parasitic species and was introduced to the United States, Hechinger estimates, decades ago.
It inhabits "freshwater springs, streams, lakes and swamps," according to the Smithsonian Environmental Research Center, but can occasionally be found in "brackish and marine habitats, especially mangroves" (think the Everglades).
The snail first popped up in California in 1972 in a Riverside County ditch, according to the center.
Hechinger, through previous and new research, found that the snail and its associated trematode parasites can be widely found in lakes and reservoirs across the state.
He's identified the snails in Los Angeles, Imperial, Orange, Riverside, San Bernardino and San Diego counties.
In summer and fall 2023, researchers, with the help of the California Department of Fish and Wildlife, analyzed fresh fish that were collected at five fishing localities in San Diego County: Miramar, Murray, Lower Otay and San Vicente reservoirs as well as Chollas Lake.
The fish included largemouth bass and bluegill.
Hechinger and his team found that 93% of all the fish in the study were infected with the H. pumilio parasite, with some individual fish harboring thousands of the parasites.
The second parasite, C. formosanus, was found at two of the five locations, where it occurred in 91% of the fish.
The parasites are each found on different parts of the fish. H. pumilio is found at the base of the fins and C. formosanus is found on the gills.
But the parasites can infect the muscles and connective tissue of the fish, Hechinger said, which is how a person eating it can get sick despite cutting off the head and fins.
"The other thing we have to remember," he said, "is the possibility of contamination on the food preparation surfaces and utensils."
The risk is real, but the precautions you can take against illness are straightforward.
Thorough cooking of any freshwater fish that could potentially be infected can prevent illness, according to the U.S. Food and Drug Administration.
If you choose to eat the fish raw, the agency advises you eat freshwater fish that has been previously frozen.
Freezing will kill parasites that may be present. However, the FDA said freezing doesn't kill all harmful germs, so the safest route is to thoroughly cook your seafood.
As part of this study, researchers conducted a survey of 125 YouTube videos with a total of 5 million views and found that 65% of these videos did not mention proper cooking or freezing of caught fish.
The lack of proper food preparation not only promotes the transmission of parasites but can also increase the odds of infection, Hechinger said.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
6 hours ago
- Miami Herald
Hershey makes major change candy lovers may not have seen coming
For those with a sweet tooth, candy is the ultimate guilty pleasure. Whether chocolate, lollipops, or gummies, these treats are undeniably addictive. Let's be honest. We often tell ourselves we'll just have one bite, but once we get a taste, it's nearly impossible to stop. Don't miss the move: Subscribe to TheStreet's free daily newsletter Many of us can relate to hiding candy from our parents as kids so they wouldn't lecture us on how bad it is for our health. Now that we are adults, we have no one to prevent us from eating an entire box of chocolates in one sitting, except ourselves. Related: Hershey adds new products to move beyond chocolate Most people aren't trying to cut out candy just because it's high in calories; they're also concerned about the added sugars, lack of nutrients, and potential health risks that come with it. Yet, the ingredients list often gets overlooked, which can be nearly as long and difficult to pronounce as a college philosophy book. Image source: Getty Images The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) recently kicked off various new measures to phase out six petroleum-based synthetic dyes from the nation's food supply by the end of next year. The intent is to encourage natural alternatives, as synthetic dyes may be linked to childhood diabetes, obesity, depression, and ADHD. Related: Hershey creates new guilt-free candy that's a dream combo "For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent," said HHS Secretary Robert F. Kennedy, Jr. "These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and era is coming to an end." This request has reached multiple states, with West Virginia becoming the first state to ban the sale of food containing artificial dyes and preservatives beginning in 2028. Texas will now require warning labels on food products containing synthetic dyes starting in 2027. Major food companies, including ConAgra Brands (CAG) , General Mills (GIS) , Tyson Foods (TSN) , and W.K. Kellogg (KLG) , have recently joined the initiative by committing to completely remove synthetic dyes by the end of 2027, with Nestlé USA (NSRGY) aiming for mid-2026. Now, Hershey (HSY) , the largest chocolate manufacturer in the U.S., is hopping on the trend, promising to remove synthetic dyes from its products by the end of 2027. More Food News: Starbucks' huge new rival opens first US storesMcDonald's brings back experimental menu item 13 years laterOreo listens to fans and brings back flavor after nearly a decade Many of the company's products, including Jolly Ranchers, Twizzlers, and Reese's Pieces, rely on synthetic dyes, and removing them would require a hefty investment if it wants to fulfill its promise. Hershey acknowledges that making these changes would increase consumer costs, but removing the dyes will provide customers with more options, while ensuring confidence and trust in its products. However, finances might be a bit tight, since net sales in its North America Confectionery sector fell 15% in the first quarter of 2025 compared to last year. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
7 hours ago
FDA vaccine official restricted COVID vaccine approvals against agency advice
WASHINGTON -- The government's top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. The new memos from the Food and Drug Administration show how the agency's vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna. Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the shots for everyone 12 and older, similar to previous COVID vaccines. The scientists had concluded the benefit from the vaccines and the risk of COVID-19 outweighed the risk of possible side effects, which are rare. Instead Prasad decided the shots should be limited to those who face special risks from the virus— seniors or children and adults with underlying medical issues. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects. It's the latest in a series of vaccine restrictions imposed by officials working under Kennedy, who has long questioned the benefits of vaccines. 'Even rare vaccination related harms both known and unknown now have higher chance of outweighing potential benefits' Prasad wrote in a five-page memo explaining his decision. COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months. Top FDA leaders are typically not involved in the review of individual products. Officials like Prasad can overrule staffers, but such cases are rare and often controversial. News of the FDA documents was first reported by the New York Times. Prasad was hired to lead the FDA's vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy. An academic researcher specializing in cancer therapies, Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. Since arriving at the agency he has worked with FDA Commissioner Mark Makary on new guidelines that will limit approvals of future COVID boosters to higher-risk Americans, mainly seniors and those with medical conditions like asthma and obesity. Those limits match the terms FDA recently approved for Novavax's shot, Nuvaxovid and Moderna's mNexspike. Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S. Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine. The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that 'the risk-benefit assessment for this vaccine technology remains favorable.' FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot. Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. In his 'override memo,' reversing FDA staff's decision on the Moderna shot, Prasad pointed to the ongoing risk of myocarditis and questions about its frequency. The agency ordered Moderna to conduct further studies of the risk as a condition for the approving its updated shot. A spokesman for the administration said Prasad 'has raised serious concerns' about the issue. 'We will not ignore these risks and will ensure that the gold standard of science is used for any decisions,' said Andrew Nixon, in an emailed statement. Outside researchers have noted that cases of the heart condition tend to resolve quickly and are less severe than those associated with COVID infection itself, which can also cause myocarditis. ___
Hamilton Spectator
7 hours ago
- Hamilton Spectator
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
WASHINGTON (AP) — The government's top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. The new memos from the Food and Drug Administration show how the agency's vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna. Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the shots for everyone 12 and older, similar to previous COVID vaccines. The scientists had concluded the benefit from the vaccines and the risk of COVID-19 outweighed the risk of possible side effects, which are rare. Instead Prasad decided the shots should be limited to those who face special risks from the virus— seniors or children and adults with underlying medical issues. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects. It's the latest in a series of vaccine restrictions imposed by officials working under Kennedy, who has long questioned the benefits of vaccines. 'Even rare vaccination related harms both known and unknown now have higher chance of outweighing potential benefits' Prasad wrote in a five-page memo explaining his decision. COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months. Top FDA leaders are typically not involved in the review of individual products. Officials like Prasad can overrule staffers, but such cases are rare and often controversial. News of the FDA documents was first reported by the New York Times. Prasad was hired to lead the FDA's vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy. An academic researcher specializing in cancer therapies , Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. Since arriving at the agency he has worked with FDA Commissioner Mark Makary on new guidelines that will limit approvals of future COVID boosters to higher-risk Americans, mainly seniors and those with medical conditions like asthma and obesity. Those limits match the terms FDA recently approved for Novavax's shot, Nuvaxovid and Moderna's mNexspike. Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S. Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine. The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that 'the risk-benefit assessment for this vaccine technology remains favorable.' FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot. Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. In his 'override memo,' reversing FDA staff's decision on the Moderna shot, Prasad pointed to the ongoing risk of myocarditis and questions about its frequency. The agency ordered Moderna to conduct further studies of the risk as a condition for the approving its updated shot. A spokesman for the administration said Prasad 'has raised serious concerns' about the issue. 'We will not ignore these risks and will ensure that the gold standard of science is used for any decisions,' said Andrew Nixon, in an emailed statement. Outside researchers have noted that cases of the heart condition tend to resolve quickly and are less severe than those associated with COVID infection itself, which can also cause myocarditis. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
